Aflatoxin and dimethyl sulfoxide influence on radiomanganese distribution and retention in neonate mice

Abstract

The LD50 (7 d) for aflatoxin B ₁ (AFB ₁ ) in CD‐1 neonate mice (3.7 g; 5 d of age) was determined to be 13.3 mg/kg. The vehicle was dimethyl sulfoxide (DMSO), given intra‐peritoneally, at 0.01 ml/animal (7 mg/kg). The solvent was nontoxic and caused no significant change in body weight in animals during an 11‐d experimental period (17 d of age). Aflatoxin B ₁ at 5.0 mg/kg and above caused reduced body weight gain. DMSO animals had a mean loss of more than 17% of the radiolabel over a 9‐d period. Aflatoxin treatments reversed the DMSO loss of ⁵⁴ Mn in a concentration‐related fashion, and generally, AFB ₁ caused a conservation of the radioisotope. The radiolabel was redistributed into the following organs/tissues: liver > brain > bone > muscle = lungs > blood. Aflatoxin‐treated animals showed a twofold increase of radiolabel in the liver as compared to controls. The DMSO itself failed to influence ⁵⁴ Mn influx into the liver. In general, control neonate mice, by 17 d of age, were retaining and redistributing the ⁵⁴ MnCl ₂ and had not reached the time for sudden emergence of excretion common in rodents. DMSO was found not to be the most satisfactory solvent to use in the administration of aflatoxins, especially when manganese metabolism is being studied. Generally, both DMSO and AFB ₁ influenced radiomanganese distribution, DMSO having a substantial influence.